Lyell Immunopharma, Inc. LYEL
16.78 USD +1.92 (+12.94%)
Nov 9, 2026, 12:54 PM EST
14.76 Day range 16.97
7.51 52-week range 38.60
- YTD
- -45.47%
- 1 year
- -4.15%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 36.00K | 61.00K | 130.00K | 84.68M | 10.65M | |
| 36.00K | 61.00K | 130.00K | 84.68M | 10.65M | |
| -269.40M | -358.75M | -247.01M | -187.06M | -214.78M | |
| -274.45M | -342.99M | -234.63M | -183.12M | -250.22M | |
| -16.06 | -26.23 | -18.70 | -14.80 | -36.80 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 61.77M | 107.29M | 145.93M | 123.83M | 294.29M | |
| 340.05M | 490.86M | 750.03M | 937.56M | 1.13B | |
| 91.85M | 108.03M | 95.08M | 104.31M | 197.62M | |
| 41.92M | 50.99M | 56.89M | 63.17M | 66.65M | |
| 248.20M | 382.82M | 654.95M | 833.25M | 929.79M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -150.02M | -162.39M | -163.69M | -169.56M | -126.25M | |
| 54.10M | 122.42M | 184.05M | -11.54M | -121.57M | |
| 50.41M | 1.33M | 1.74M | 10.63M | 401.24M | |
| -493.00K | -464.00K | -2.69M | -24.28M | -65.50M | |
| -45.52M | -38.64M | 22.10M | -170.46M | 153.42M |